432

Compound name
Palbociclib
Alt Name
Ibrance
PD-0332991
PD0332991
Compound Image
Palbociclib.png
SMILES
CC1=C(C(=O)N(C2=NC(=NC=C12)NC3=NC=C(C=C3)N4CCNCC4)C5CCCC5)C(=O)C
MW
447.50
Brutto
C24H29N7O2
InChI
InChI=1S/C24H29N7O2/c1-15-19-14-27-24(28-20-8-7-18(13-26-20)30-11-9-25-10-12-30)29-22(19)31(17-5-3-4-6-17)23(33)21(15)16(2)32/h7-8,13-14,17,25H,3-6,9-12H2,1-2H3,(H,26,27,28,29)
InChI Key
AHJRHEGDXFFMBM-UHFFFAOYSA-N
Approval Jurisdiction
2015 FDA 2016 EMA
Approved for clinical use
Advanced (Metastatic) Breast Cancer
CAS
571190-30-2
PubChem CID
5330286
Action
CDK4/6
Approved Drug List
1
Commercial Vendor
Pfizer